You have 9 free searches left this month | for more free features.

Condition

Healthy (2)

Alopecia Areata (1)

Crohn Disease (1)

Overall Status

Withdrawn (3)

Completed (1)

Sign in for free

Phase

phase 1 (2)

phase 2 (2)

Sponsor

Janssen Research & Development, LLC (3)

Janssen Pharmaceutical K.K. (1)

Collaborator

Intervention

jnj-64304500 (4)

placebo (3)

adalimumab (1)

ustekinumab (1)

Study Documents

Intervention Type

drug (4)

Funder Type

Industry (4)

Study Type

Interventional (4)

jnj-64304500

Showing 1 - 4 of 4

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Healthy Trial in Beijing (JNJ-64304500)

Withdrawn

Healthy

JNJ-64304500

Beijing, China

Peking University Third Hospital

Aug 30, 2021

Crohn Disease Trial in Evansville (JNJ-64304500, Placebo, Adalimumab)

Withdrawn

Crohn Disease

JNJ-64304500
+3 more

Evansville, Indiana

Medisphere Medical Research Center, Llc

Aug 30, 2021

Alopecia Areata Trial in Worldwide (JNJ-64304500, Placebo)

Withdrawn

Alopecia Areata

JNJ-64304500
Placebo

Tampa, Florida
+21 more

Apr 29, 2021

Healthy Trial in Tokyo (JNJ-64304500, Placebo)

Completed

Healthy

JNJ-64304500
Placebo

Tokyo, Japan

(unnamed)

Sep 27, 2017